Journal article

Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence


Authors listBonn, Bettina R.; Rohde, Marius; Zimmermann, Martin; Krieger, David; Oschlies, Ilske; Niggli, Felix; Wrobel, Grazyna; Attarbaschi, Andishe; Escherich, Gabriele; Klapper, Wolfram; Reiter, Alfred; Burkhardt, Birgit

Publication year2013

Pages3153-3160

JournalBlood

Volume number121

Issue number16

ISSN0006-4971

eISSN1528-0020

Open access statusGreen

DOI Linkhttps://doi.org/10.1182/blood-2012-12-474148

PublisherAmerican Society of Hematology (ASH Publications)


Abstract
Probability of event-free survival (pEFS) in pediatric T-cell lymphoblastic lymphoma is about 80%, whereas survival in relapsed patients is very poor. No stratification criteria have been established so far. Recently, activating NOTCH1 mutations were reported to be associated with favorable prognosis, and loss of heterozygosity at chromosome 6q (LOH6q) was reported to be associated with increased relapse risk. The current project was intended to evaluate the prognostic effect of these markers. Mutations in hot spots of NOTCH1 and FBXW7 were analyzed in 116 patients. Concerning LOH6q status, 118 patients were investigated, using microsatellite marker analysis, in addition to an earlier reported cohort of 99 available patients. Ninety-two cases were evaluable for both analyses. All patients were treated with T-cell lymphoblastic lymphoma-Berlin-Frankfurt-Munster group (BFM)-type treatment. LOH6q was observed in 12% of patients (25/217) and associated with unfavorable prognosis (pEFS 27% +/- 9% vs 86% +/- 3%; P < .0001). In 60% (70/116) of the patients, NOTCH1 mutations were detected and associated with favorable prognosis (pEFS 84% +/- 5% vs 66% +/- 7%; P = .021). Interestingly, NOTCH1 mutations were rarely observed in patients with LOH in 6q16. Both prognostic markers will be used as stratification criteria in coming Non-Hodgkin Lymphoma-BFM trials.



Citation Styles

Harvard Citation styleBonn, B., Rohde, M., Zimmermann, M., Krieger, D., Oschlies, I., Niggli, F., et al. (2013) Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence, Blood, 121(16), pp. 3153-3160. https://doi.org/10.1182/blood-2012-12-474148

APA Citation styleBonn, B., Rohde, M., Zimmermann, M., Krieger, D., Oschlies, I., Niggli, F., Wrobel, G., Attarbaschi, A., Escherich, G., Klapper, W., Reiter, A., & Burkhardt, B. (2013). Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood. 121(16), 3153-3160. https://doi.org/10.1182/blood-2012-12-474148



Keywords


CYTOGENETIC ABNORMALITIESFBXW7 MUTATIONSHETEROZYGOSITYHIGH-DOSE METHOTREXATELEUKEMIANOTCH1 MUTATIONS

Last updated on 2025-10-06 at 10:13